Chambal Fertilisers and Chemicals (CHAMBLFERT) Q4 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 23/24 earnings summary
22 Sep, 2026Executive summary
Revenue from operations for FY 2023-24 was ₹17,966.41 crore, down 35% year-over-year, mainly due to lower prices and volumes of own manufactured and imported fertilisers, and lower natural gas prices.
Profit after tax increased to ₹1,331.44 crore from ₹1,069.31 crore year-over-year, driven by improved margins, lower finance costs, and higher other income.
Total comprehensive income for the year was ₹1,423.78 crore, up from ₹1,004.43 crore in the previous year.
Financial highlights
EBITDA and operating profit margin improved significantly due to lower input costs and better performance in non-urea segments.
Net profit margin rose to 7.41% from 3.85% year-over-year.
Debt-equity ratio improved to 0.25 from 0.47, reflecting substantial debt reduction.
Interest coverage ratio more than doubled to 12.22 from 5.54.
Return on net worth increased to 19.02% from 16.38% year-over-year.
Outlook and guidance
Continued strong demand for urea and agri-inputs expected, with stable performance in urea and growth in crop protection chemicals and speciality nutrients.
Technical Ammonium Nitrate plant project progressing on schedule, expected to diversify revenue streams.
Geographical expansion and deeper market penetration targeted for sustainable growth.
Latest events from Chambal Fertilisers and Chemicals
- Q1 FY27 delivered higher margins and profit despite lower revenue, with strong segment performance.CHAMBLFERT
Q1 26/27 - FY26 saw 25% revenue growth, 18% profit rise, and major TAN plant commissioning.CHAMBLFERT
Q4 25/26 - Diversified agri-input leader with strong financials, expanding into industrial chemicals and sustainability.CHAMBLFERT
Investor presentation - Strong Q3/9M growth driven by complex fertilizers, specialty nutrients, and TAN project progress.CHAMBLFERT
Q3 25/26 - Strong revenue and profit growth, new launches, and interim dividend highlight robust performance.CHAMBLFERT
Q2 25/26 - EBITDA and PAT rose sharply, with zero long-term debt and strong crop protection growth.CHAMBLFERT
Q1 24/25 - EBITDA and PAT surged year-over-year, supported by urea and CPCSM growth, and interim dividend declared.CHAMBLFERT
Q2 24/25 - Q3 saw strong profit and revenue growth, new product launches, and major capacity expansions.CHAMBLFERT
Q3 24/25 - EBITDA and PAT rose in FY25, led by CPC & SN growth; Rs. 5.00/share dividend recommended.CHAMBLFERT
Q4 24/25